EX-10.2



 Exhibit 10.2 

AMENDED AND RESTATED EMPLOYMENT AGREEMENT 

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), effective as of June 24, 2014 (the “Effective
Date”), is entered into by Cerulean Pharma Inc., a Delaware corporation with its principal place of business at 840 Memorial Drive, 5th Floor, Cambridge, MA 02139 (the “Company”),
and Oliver Fetzer (the “Employee”). This Agreement amends and restates in its entirety the Employment Agreement between the Company and the Employee dated April 8, 2009. 

The Company desires to continue to employ the Employee and the Employee desires to continue to be employed by the Company. In consideration of
the mutual covenants and promises contained herein, and other good and valuable consideration, the receipt and sufficiency of which are acknowledged by the parties hereto, the parties agree as follows: 

1. Term of Employment. The Company hereby agrees to continue to employ the Employee and the Employee hereby accepts continued
employment with the Company, upon the terms set forth in this Agreement. There shall be no definite term of employment, and the Employee’s employment shall be at-will such that both the Company and the Employee remain free to end the employment
relationship for any reason, at any time, with or without notice. 
 2. Title and Capacity. The Employee shall serve (i) as
President and Chief Executive Officer of the Company and shall report to the Board of Directors of the Company (the “Board”) and (ii) while President and Chief Executive Officer of the Company, as a member of the Board. The Employee
shall be based at the Company’s headquarters in Cambridge, Massachusetts. 
 The Employee agrees to undertake the duties and
responsibilities inherent in such position and such other duties and responsibilities as the Board shall from time to time 

  
 1 








 
reasonably assign to him. The Employee agrees to devote his entire business time, attention and energies to the business and interests of the Company. Except for service on the boards of
directors on which he currently serves and/or as specifically approved by the Board, the Employee agrees to abide by the rules, regulations, instructions, personnel practices and policies of the Company and any changes therein that may be adopted
from time to time by the Company. 
 3. Compensation and Benefits. 

3.1 Base Salary. The Company shall pay the Employee, in accordance with the Company’s regular payroll practices, a base salary at
the annualized rate of $425,000 effective as of the Effective Date, subject to adjustment thereafter by the Board. 
 3.2 Bonus. In
addition to a base salary, the Employee will be eligible to receive a performance-based annual bonus for each fiscal year in which he is employed by the Company in the capacity of President and Chief Executive Officer. This bonus shall be based upon
reasonably attainable annual quantitative and qualitative performance objectives that will be mutually agreed upon by the Board and the Employee. The Employee’s annual bonus level target has been set at fifty percent (50%) of the
Employee’s base salary. The Board will determine, in its sole discretion, based upon its review of the achievement of the performance objectives for a given fiscal year and its consideration of the recommendation of the Compensation Committee,
whether (and in what amount) a bonus award is payable to the Employee. 
 To be eligible to receive a bonus award, the Employee must be an
active employee on the date any such bonuses are distributed. 

  
 2 








 3.3 Employee Benefits. The Employee shall be entitled to participate in all benefit plans
and programs that the Company establishes and makes available to its employees to the extent that the Employee is eligible under (and subject to the provisions of) the plan documents governing those programs. The Employee shall be entitled to
twenty-five (25) days paid vacation per year plus personal days and paid holidays generally offered by the Company to its employees, each to be administered in accordance with Company policy. 

3.4 Reimbursement of Expenses. The Company shall reimburse the Employee for all reasonable travel, entertainment and other expenses
incurred or paid by the Employee in connection with, or related to, the performance of his duties, responsibilities or services under this Agreement in accordance with the Company’s expense reimbursement policies as set forth in the
Company’s employee handbook, a copy of which has been provided to the Employee. The reimbursement of expenses hereunder shall be subject to the terms and conditions set forth in Section 18(e) of this Agreement. 

3.5 Withholding. All salary, bonus and other compensation or benefits payable to the Employee shall be subject to applicable
withholdings and taxes. 
 4. Payments Upon Resignation By The Employee Without Good Reason or Termination By The Company For Cause.

 4.1 Payment upon Voluntary Resignation or Termination for Cause. If the Employee voluntarily resigns his employment other than for
Good Reason (as defined in Section 4.2), or if the Company terminates the Employee for Cause (as defined in Section 4.3), the Company shall pay the Employee all accrued and unpaid base salary through the Employee’s date of termination
and any vacation that is accrued but unused as of such date. The Employee shall not be eligible for any severance or separation payments (including, but not limited to, 

  
 3 








 
those described in Sections 5, 6 and 7 of this Agreement) or any continuation of benefits (other than those provided for under the Federal Consolidated Omnibus Budget Reconciliation Act
(“COBRA”)), or any other compensation pursuant to this Agreement or otherwise. The Employee also shall have such rights, if any, with respect to outstanding equity awards as may be provided under the agreement applicable to each. 

4.2 Definition of “Good Reason”. For purposes of this Agreement, “Good Reason” means the occurrence, without the
Employee’s written consent, of any of the events or circumstances set forth in clauses (a) through (c) below, provided, however, that an event described in clauses (a) through (c) below shall not constitute
Good Reason unless it is communicated in writing, within 90 days of the first occurrence of an event giving rise to the claim, by the Employee to the Board or its successor and unless it is not corrected by the Company or its successor within thirty
(30) days of the Company’s receipt of such written notice: 
 (a) the assignment to the Employee of duties inconsistent in any
material respect with the Employee’s position (including status, offices, titles and reporting requirements), authority or responsibilities, or any other action or omission by the Company, in each case which results in a material diminution of
the Employee’s duties, authority or responsibilities; 
 (b) a material reduction in the Employee’s base salary; or 

(c) a change by the Company in the location at which the Employee performs his principal duties for the Company to a new location that is
both (i) outside a radius of 50 miles from the Employee’s principal residence and (ii) more than 30 miles from the location at which the Employee performed his principal duties for the Company. 

  
 4 








 If the Company fails to timely correct an event of Good Reason, the termination of
Executive’s employment shall become effective 60 days after such notice is received by the Company. 
 4.3 Definition of
“Cause”. For purposes of this Agreement, “Cause” is defined as: (i) a good faith finding by the Board (excluding the Employee, if applicable) of (a) the Employee’s failure to (1) perform reasonably
assigned lawful duties or (2) comply with a lawful instruction of the Board so long as, in the case of (2), the instruction is consistent with the scope and responsibilities of the Employee’s position, or (b) the Employee’s
dishonesty, willful misconduct or gross negligence, or (c) the Employee’s substantial and material failure or refusal to perform according to, or to comply with, the policies, procedures or practices established by the Company or the Board
and, in the case of (a) or (c), the Employee has had ten (10) days written notice to cure his failure to so perform or comply; or (ii) the Employee’s indictment, or the entering of a guilty plea or plea of “no contest”
with respect to a felony or any crime involving moral turpitude. 
 5. Termination Without Cause; Resignation for Good Reason. If the
Employee’s employment with the Company is terminated by the Company without Cause (as defined in Section 4.3), or by the Employee’s voluntary resignation for Good Reason (as defined in Section 4.2), other than in connection with
a Change in Control (as defined in Section 7.2(a)), then the Employee shall be paid all accrued and unpaid base salary and any accrued but unused vacation through the date of termination. In addition, subject to the Employee’s execution
and non-revocation of a binding severance and mutual release agreement in a form satisfactory to the 

  
 5 








 
Company (hereinafter, a “Severance Agreement”) and subject to the terms and conditions of Section 18 of this Agreement, the Employee shall be eligible to receive the following
separation benefits: 
 5.1 an amount equal to (i) nine (9) months of the Employee’s then-current base salary
(provided, however, that if Employee’s employment is terminated by the Employee’s voluntary resignation for Good Reason as a result of the Company’s material reduction of the Employee’s base salary, then the
Employee’s then-current base salary shall refer to his base salary as in effect immediately before such material reduction took effect) plus (ii) an amount equal to three-fourths (3/4) of the Employee’s target performance-based
annual bonus pursuant to Section 3.2 for the year in which the Employee’s date of termination occurs, all of which shall be payable, in full and in a lump-sum cash payment (subject to applicable withholdings), on the Payment Commencement
Date, provided that the Severance Agreement has been executed and any applicable revocation period with respect thereto has expired within thirty (30) days following the Employee’s date of termination (such 30th day, the “Payment Commencement Date”); provided, however, that if the 30th day following the Employee’s date of
termination occurs in the calendar year following the year of termination, then the Payment Commencement Date shall be no earlier than January 1 of the year following the year of termination; and 

5.2 upon the Employee’s termination from employment pursuant to this Section 5, the Company shall continue the Employee and his
dependents on its medical and dental plans in accordance with the applicable plans, or to the extent the Employee and his dependents cannot be maintained on such plans, the Company will obtain comparable policies for the Employee and shall pay only
that portion of the medical and dental premiums that it pays on behalf of its actively employed executives who receive the same type of coverage for a period of nine (9) months after the Employee’s termination; provided,
however, that if the Employee 

  
 6 








 
becomes re-employed with another employer and is eligible to receive such benefits from such employer on terms at least as favorable to the Employee and his dependents as those being provided by
the Company, then the Company shall no longer be required to provide those particular benefits to the Employee and his dependents. At the end of the nine (9) month period, the Employee may continue such policies on his own behalf or pursuant to
COBRA, if applicable, and shall be responsible for all premiums thereafter. 
 6. Termination by Reason of Death or Disability. 

6.1 If the Employee’s employment with the Company is terminated by reason of the Employee’s death or Disability (as defined below),
then the Employee (or his estate, if applicable) shall be paid, within thirty (30) days of the date of the Employee’s death or determination of Disability, all accrued and unpaid base salary and any accrued but unused vacation through the
date of termination. In addition, subject to the execution and non-revocation of a Severance Agreement by the Employee, his estate or his legal representative(s), as applicable, and the terms and conditions set forth in Section 18 of this
Agreement, the Employee or his estate, as applicable, shall also be eligible to receive an annual bonus in an amount equal to the total bonus, if any, that he would have been paid for the year in which his termination by reason of death or
Disability occurred, pro-rated for the length of service since the last bonus period. This pro-rata bonus, if any, shall be payable in a lump sum on the Payment Commencement Date. 

6.2 For purposes of this Agreement, “Disability” shall mean the Employee’s absence from the full-time performance of the
Employee’s duties with the Company for 180 consecutive calendar days as a result of incapacity due to mental or physical illness which is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable
to the Employee or the Employee’s legal representative. 

  
 7 








 7. Termination Following Change of Control. 

7.1 Benefits to Employee Upon a Change of Control Termination. In the event of a Change of Control Termination (as defined in
Section 7.2(c) below), the Employee shall be entitled to all accrued and unpaid base salary and any accrued but unused vacation through the date of termination. In addition, subject to the Employee’s execution and non-revocation of a
binding Severance Agreement and the terms and conditions set forth in Section 18 of this Agreement, the Employee shall be eligible to receive the following separation benefits: 

(a) the separation benefits described in and payable at the time and in the manner set forth in Sections 5.1 and 5.2 above, except that all
references to “nine (9) months” in such Sections shall be replaced with “twelve (12) months” for purposes of this Section 7, and the words “three-fourths (3/4) of” in Section 5.1 shall be
deleted; and 
 (b) full and immediate vesting of any equity awards subject to time-based vesting that are outstanding at the time of the
termination of the Employee’s employment. Any of the Employee’s outstanding awards at the time of the termination will remain exercisable following termination to the extent set forth in the applicable award agreements. 

7.2 Key Definitions. As used herein, the following terms shall have the following respective meanings: 

(a) “Change in Control” means an event or occurrence set forth in any one or more of subsections (i) through
(iii) below (including an event or occurrence that constitutes a Change in Control under one of such subsections but is specifically exempted from another such subsection): 

(i) the acquisition by an individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership of any capital stock of the 

  
 8 








 
Company if, after such acquisition, such Person beneficially owns (within the meaning of Rule 13d-3 promulgated under the Exchange Act) more than 50% of either (x) the then-outstanding
shares of common stock of the Company (the “Outstanding Company Common Stock”) or (y) the combined voting power of the then-outstanding securities of the Company entitled to vote generally in the election of directors (the
“Outstanding Company Voting Securities”); or 
 (ii) the consummation of a merger, consolidation, reorganization,
recapitalization or share exchange involving the Company or a sale or other disposition of all or substantially all of the assets of the Company in one or a series of transactions (a “Business Combination”), unless, immediately following
such Business Combination, all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding securities entitled to vote generally in the election of directors, respectively, of the
resulting or acquiring corporation in such Business Combination (which shall include, without limitation, a corporation which as a result of such transaction owns the Company or substantially all of the Company’s assets either directly or
through one or more subsidiaries) (such resulting or acquiring corporation is referred to herein as the “Acquiring Corporation”) in substantially the same proportions as their ownership, immediately prior to such Business Combination, of
the Outstanding Company Common Stock and Outstanding Company Voting Securities, respectively; or 

  
 9 








 (iii) approval by the stockholders of the Company of a complete or substantially complete
liquidation or dissolution of the Company. 
 (b) “Change in Control Date” means the first date during the period of time
the Employee is employed pursuant to this Agreement on which a Change in Control occurs. Anything in this Agreement to the contrary notwithstanding, if (a) a Change in Control occurs, (b) the Employee’s employment with the Company is
terminated prior to the date on which the Change in Control occurs, and (c) it is reasonably demonstrated by the Employee that such termination of employment (i) was at the request of a third party who has taken steps reasonably calculated
to effect a Change in Control or (ii) otherwise arose in connection with or in anticipation of a Change in Control, then for all purposes of this Agreement the “Change in Control Date” shall mean the date immediately prior to the date
of such termination of employment. 
 (c) Change of Control Termination occurs where the Employee is terminated without Cause (as
defined in Section 4.3) or resigns for Good Reason (as defined in Section 4.2), in either case within twelve (12) months following the Change in Control Date. 

8. Mitigation. The Employee shall not be required to mitigate the amount of any payment or benefits provided for in Sections 5 or
7 by seeking other employment or otherwise except with regard to medical and dental coverage if new employment is obtained. 

  
 10 








 9. Survival. The provisions of Sections 5, 6 and 7 shall survive the termination of
this Agreement for any reason. 
 10. Invention and Non-Disclosure Agreement. The Employee and the Company acknowledge (a) that
they have entered into an Invention and Non-Disclosure Agreement effective as of April 8, 2009 and (b) the continuing effectiveness of such Invention and Non-Disclosure Agreement. 

11. Notices. Any notices delivered under this Agreement shall be deemed duly delivered three (3) business days after it is sent by
registered or certified mail, return receipt requested, postage prepaid, or one (1) business day after it is sent for next-business day delivery signature required via a reputable nationwide overnight courier service, to the Company’s
address set forth in the introductory paragraph hereto or to the home address of the Employee then on file with the Company, as applicable. Either party may change the address to which notices are to be delivered by giving notice of such change to
the other party in the manner set forth in this Section 11. 
 12. Pronouns. Whenever the context may require, any pronouns used
in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular forms of nouns and pronouns shall include the plural, and vice versa. 

13. Entire Agreement. This Agreement and all exhibits hereto constitute the entire agreement between the parties and supersedes all
prior agreements and understandings, whether written or oral, relating to the subject matter of this Agreement. 
 14. Amendment.
This Agreement may be amended or modified only by a written instrument executed by both the Company and the Employee. 

  
 11 








 15. Governing Law. This Agreement shall be governed by and construed in accordance with
the laws of the Commonwealth of Massachusetts (without reference to the conflict of laws provisions thereof). Any action, suit or other legal proceeding arising under or relating to any provision of this Agreement shall be commenced only in a court
of the Commonwealth of Massachusetts (or, if appropriate, a federal court located within the Commonwealth of Massachusetts), and the Company and the Employee each consents to the jurisdiction of such a court. The Company and the Employee each hereby
irrevocably waive any right to a trial by jury in any action, suit or other legal proceeding arising under or relating to any provision of this Agreement. 

16. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of both parties and their respective
successors and assigns, including any corporation with which or into which the Company may be merged or which may succeed to its assets or business; provided, however, that the obligations of the Employee are personal and shall not be
assigned by him. 
 17. Acknowledgment. The Employee states and represents that he has had an opportunity to fully discuss and review
the terms of this Agreement with an attorney. The Employee further states and represents that he has carefully read this Agreement, understands the contents herein, freely and voluntarily assents to all of the terms and conditions hereof, and signs
his name of his own free act. 

  
 12 








 18. Payments Subject to Section 409A. Subject to the provisions in this
Section 18, any severance payments or benefits under this Agreement shall begin only upon the date of the Employee’s “separation from service” (determined as set forth below) which occurs on or after the date of termination of
the Employee’s employment. The following rules shall apply with respect to distribution of the payments and benefits, if any, to be provided to the Employee under this Agreement: 

(a) It is intended that each installment of the severance payments and benefits provided under this Agreement shall be treated as a separate
“payment” for purposes of Section 409A of the Internal Revenue Code of 1986, as amended and the guidance issued thereunder (“Section 409A”). Neither the Company nor the Employee shall have the right to accelerate or defer
the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A. 
 (b) If, as
of the date of the Employee’s “separation from service” from the Company, the Employee is not a “specified employee” (within the meaning of Section 409A), then each installment of the severance payments and benefits
shall be made on the dates and terms set forth in this Agreement. 
 (c) If, as of the date of the Employee’s “separation from
service” from the Company, the Employee is a “specified employee” (within the meaning of Section 409A), then: 
 (i)
Each installment of the severance payments and benefits due under this Agreement that, in accordance with the dates and terms set forth herein, will in all circumstances, regardless of when the separation from service occurs, be paid within the
short-term deferral period (as defined under Section 409A) shall be treated as a short-term deferral within the meaning of Treasury Regulation § 1.409A-1(b)(4) to the maximum extent permissible under Section 409A and shall be paid in
the manner (and at the times) set forth in this agreement; and 

  
 13 








 (ii) Each installment of the severance payments and benefits due under this Agreement that is
not described in paragraph c(i) above and that would, absent this subsection, be paid within the six-month period following the Employee’s “separation from service” from the Company shall not be paid until the date that is six months
and one day after such separation from service (or, if earlier, the Employee’s death), with any such installments that are required to be delayed being accumulated during the six-month period and paid in a lump sum on the date that is six
months and one day following the Employee’s separation from service and any subsequent installments, if any, being paid in accordance with the dates and terms set forth herein; provided, however, that the preceding provisions of
this sentence shall not apply to any installment of severance payments and benefits if and to the maximum extent that that such installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by
reason of the application of Treasury Regulation § 1.409A-1(b)(9)(iii) (relating to separation pay upon an involuntary separation from service). Any installments that qualify for the exception under Treasury Regulation
§ 1.409A-1(b)(9)(iii) must be paid no later than the last day of the Employee’s second taxable year following the taxable year in which the separation from service occurs. 

(d) The determination of whether and when the Employee’s separation from service from the Company has occurred shall be made and in a
manner consistent with, and based on the presumptions set forth in, Treasury Regulation § 1.409A-1(h). 
 (e) All reimbursements and
in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where
applicable, the requirements that (i) any reimbursement is for expenses incurred during the 

  
 14 








 
Employee’s lifetime (or during a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the
expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred and (iv) the
right to reimbursement is not subject to set off or liquidation or exchange for any other benefit. 
 (f) Notwithstanding anything herein
to the contrary, the Company shall have no liability to the Employee or to any other person if the payments and benefits provided hereunder that are intended to be exempt from or compliant with Section 409A are not so exempt or compliant. 

19. Miscellaneous. 
 19.1
No delay or omission by the Company in exercising any right under this Agreement shall operate as a waiver of that or any other right. A waiver or consent given by the Company on any one occasion shall be effective only in that instance and shall
not be construed as a bar to or waiver of any right on any other occasion. 
 19.2 The captions of the sections of this Agreement are for
convenience of reference only and in no way define, limit or affect the scope or substance of any section of this Agreement. 
 19.3 In case
any provision of this Agreement shall be invalid, illegal or otherwise unenforceable, the validity, legality and enforceability of the remaining provisions shall in no way be affected or impaired thereby. 

[remainder of page intentionally left blank] 

  
 15 








 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year set
forth above. 
  

			
	CERULEAN PHARMA INC.
	
	 /s/ Robert I. Tepper

	By:	 	Robert I. Tepper, M.D.
	Title:	 	Chairman, Compensation Committee of the Board of Directors
	
	EMPLOYEE
	 /s/ Oliver Fetzer

	Oliver Fetzer, Ph.D.



  
 16